Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- cyclosporine ophthalmic
- dexamethasone / ketorolac / moxifloxacin ophthalmic
Interactions between your drugs
ketorolac ophthalmic dexAMETHasone ophthalmic
Applies to: dexamethasone / ketorolac / moxifloxacin ophthalmic, dexamethasone / ketorolac / moxifloxacin ophthalmic
GENERALLY AVOID: Concomitant use of ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) and ophthalmic steroids may increase the potential for healing problems, as both can slow or delay healing.
MANAGEMENT: The use of ophthalmic NSAIDs in combination with ophthalmic corticosteroids should be avoided unless benefits outweigh the potential risks.
References (3)
- (2001) "Product Information. Acular (ketorolac)." Allergan Inc
- (2005) "Product Information. Xibrom (bromfenac ophthalmic)." ISTA Pharmaceuticals
- (2005) "Product Information. Nevanac (nepafenac ophthalmic)." Alcon Laboratories Inc
dexAMETHasone ophthalmic cycloSPORINE ophthalmic
Applies to: dexamethasone / ketorolac / moxifloxacin ophthalmic, cyclosporine ophthalmic
MONITOR: Coadministration with eye drops containing corticosteroids may potentiate the immunosuppressant effects of cyclosporine eye drops.
MANAGEMENT: Caution is recommended if corticosteroid-containing eye drops and cyclosporine-containing eye drops are used concomitantly. Eye examination at 6-monthly intervals are recommended if cyclosporine eye drops are intended for long-term use.
References (2)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Restasis
Restasis is used to treat chronic dry eye that may be caused by inflammation. Learn about side ...
Chantix
Chantix is a smoking cessation medicine used with behavior modification and counseling to help you ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Xiidra
Xiidra (lifitegrast 5%) is an eye drop solution that is used twice daily in each eye to treat the ...
Miebo
Miebo (perfluorohexyloctane) is used to treat the signs and symptoms of dry eye disease. Includes ...
Cequa
Cequa (cyclosporine ophthalmic) is a prescription eye drop used to treat chronic dry eye from ...
Lotemax
Lotemax and Lotemax SM (loteprednol etabonate) are corticosteroid medications used to help treat ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.